Bevacizumab Plus EGFR-TKIs in Chinese Patients With EGFR-mutant NSCLC: a Real-world Study
Clinical trial NCT04575415 · UNKNOWN
Trial details
- NCT number
- NCT04575415
- Sponsor
- Guangdong Association of Clinical Trials
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-10-07
- Primary completion
- 2023-05-01
- Enrollment
- 272
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.